-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Shuttle Pharmaceuticals (NASDAQ:SHPH) Stock Price Up 2.8%
Shuttle Pharmaceuticals (NASDAQ:SHPH) Stock Price Up 2.8%
Shares of Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH – Get Rating) rose 2.8% during trading on Wednesday . The stock traded as high as $4.69 and last traded at $4.07. Approximately 4,816,542 shares were traded during mid-day trading, a decline of 3% from the average daily volume of 4,981,639 shares. The stock had previously closed at $3.96.
Shuttle Pharmaceuticals Stock Up 2.8 %
Shuttle Pharmaceuticals Company Profile
(Get Rating)
Shuttle Pharmaceuticals Holdings, Inc, through its subsidiary, Shuttle Pharmaceuticals, Inc, focuses on the discovery, development, and commercialization of drugs for sensitizing cancers to radiation therapy. Its products in clinical stage include Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and soft tissue sarcomas; and Doranidazole, an injectable hypoxic cell radiation sensitizer for treatment of pancreatic, lung, and liver cancers.
Further Reading
- Get a free copy of the StockNews.com research report on Shuttle Pharmaceuticals (SHPH)
- 3 Alzheimer Stocks to Buy as the Race for a Cure Heats Up
- Don't Forget About These Cheap, Fundamentally Strong Tech Stocks
- Bellwether RPM International Pops On Results
- Rivian Checks Off Boxes, But Still Needs a Lot to Go Right
- Hot Potato: Lamb Weston Stock Confirms a Top
Receive News & Ratings for Shuttle Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shuttle Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
Shares of Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH – Get Rating) rose 2.8% during trading on Wednesday . The stock traded as high as $4.69 and last traded at $4.07. Approximately 4,816,542 shares were traded during mid-day trading, a decline of 3% from the average daily volume of 4,981,639 shares. The stock had previously closed at $3.96.
納斯達克的股票週三在交易中上漲了2.8%。該股盤中一度漲至4.69美元,最新報4.07美元。午盤成交量約為4,816,542股,較日均成交量4,981,639股下降3%。該股此前收盤價為3.96美元。
Shuttle Pharmaceuticals Stock Up 2.8 %
航天飛機制藥類股上漲2.8%
Shuttle Pharmaceuticals Company Profile
航天飛機制藥公司簡介
(Get Rating)
(獲取評級)
Shuttle Pharmaceuticals Holdings, Inc, through its subsidiary, Shuttle Pharmaceuticals, Inc, focuses on the discovery, development, and commercialization of drugs for sensitizing cancers to radiation therapy. Its products in clinical stage include Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and soft tissue sarcomas; and Doranidazole, an injectable hypoxic cell radiation sensitizer for treatment of pancreatic, lung, and liver cancers.
Shuttle製藥控股公司通過其子公司Shuttle PharmPharmticals,Inc專注於使癌症對放射療法敏感的藥物的發現、開發和商業化。其臨牀階段的產品包括用於治療腦腫瘤和軟組織肉瘤患者的口服滷代嘧啶核苷,以及用於治療胰腺癌、肺癌和肝癌的注射低氧細胞輻射增敏劑多拉硝唑。
Further Reading
進一步閲讀
- Get a free copy of the StockNews.com research report on Shuttle Pharmaceuticals (SHPH)
- 3 Alzheimer Stocks to Buy as the Race for a Cure Heats Up
- Don't Forget About These Cheap, Fundamentally Strong Tech Stocks
- Bellwether RPM International Pops On Results
- Rivian Checks Off Boxes, But Still Needs a Lot to Go Right
- Hot Potato: Lamb Weston Stock Confirms a Top
- 免費獲取StockNews.com關於Shuttle PharmPharmticals(SHPH)的研究報告
- 隨着治療競賽升温,3只阿爾茨海默病股票將被買入
- 不要忘記這些廉價的、從根本上強勁的科技股
- 領頭羊RPM國際流行業績
- Rivian打掉了包袱,但仍有很多事情要做
- 辣土豆:韋斯頓羊肉庫存漲幅居前
Receive News & Ratings for Shuttle Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shuttle Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
接受《穿梭藥業日報》的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對Shuttle PharmPharmticals和相關公司的最新新聞和分析師評級的每日摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧